A Phase I Study of JSKN021 in Advanced Solid Tumors

Clinical trial NCT07617727 · RECRUITING

Trial details

NCT number: NCT07617727
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2026-06-02
Primary completion: 2028-10-31
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.